Observational analysis shows increased TCF1 expression in T cell subsets during IL-12 immunocytokine therapy for advanced tumors, suggesting potential immune response enhancement.
Supplementary Figure 4. TCF1 expression across T cell subsets before and during PDS01ADC therapy
No takes yet. Share an insight, caveat, or question.
Goswami et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: